BET bromodomain proteins regulate enhancer function during adipogenesis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29444854.
- Also identified by DOI 10.1073/pnas.1711155115 and PMC identifier 5834672.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Developmental transitions are guided by master regulatory transcription factors. During adipogenesis, a transcriptional cascade culminates in the expression of PPARγ and C/EBPα, which orchestrate activation of the adipocyte gene expression program. However, the coactivators controlling PPARγ and C/EBPα expression are less well characterized. Here, we show the bromodomain-containing protein, BRD4, regulates transcription of PPARγ and C/EBPα. Analysis of BRD4 chromatin occupancy reveals that induction of adipogenesis in 3T3L1 fibroblasts provokes dynamic redistribution of BRD4 to de novo super-enhancers proximal to genes controlling adipocyte differentiation. Inhibition of the bromodomain and extraterminal domain (BET) family of bromodomain-containing proteins impedes BRD4 occupancy at these de novo enhancers and disrupts transcription of <i>Pparg</i> and <i>Cebpa</i>, thereby blocking adipogenesis. Furthermore, silencing of these BRD4-occupied distal regulatory elements at the <i>Pparg</i> locus by CRISPRi demonstrates a critical role for these enhancers in the control of <i>Pparg</i> gene expression and adipogenesis in 3T3L1s. Together, these data establish BET bromodomain proteins as time- and context-dependent coactivators of the adipocyte cell state transition.
Medical subject headings
- Adipocytes
- Adipose Tissue
- Gene Expression Regulation
- Nuclear Proteins
- Transcription Factors